182 related articles for article (PubMed ID: 34183756)
21. Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria.
Amaeze O; Eng H; Horlbogen L; Varma MVS; Slitt A
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):437-450. PubMed ID: 33844145
[TBL] [Abstract][Full Text] [Related]
22. A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.
Brantley SJ; Graf TN; Oberlies NH; Paine MF
Drug Metab Dispos; 2013 Sep; 41(9):1662-70. PubMed ID: 23801821
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of metabolism-mediated herb-drug interactions.
Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
[TBL] [Abstract][Full Text] [Related]
25. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
26. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
[TBL] [Abstract][Full Text] [Related]
27. Herb-drug interaction between Shaoyao-Gancao-Fuzi decoction and tofacitinib via CYP450 enzymes.
Lin L; Wang Y; Shao S; Lin W; Huang D; Dai Y; Xia Y
J Ethnopharmacol; 2022 Sep; 295():115437. PubMed ID: 35667582
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic interaction between a Chinese herbal formula Huosu Yangwei oral liquid and apatinib in vitro and in vivo.
Fang SQ; Huang J; Zhang F; Ni HM; Chen QL; Zhu JR; Fu ZC; Zhu L; Hao WW; Ge GB
J Pharm Pharmacol; 2020 Jul; 72(7):979-989. PubMed ID: 32285478
[TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulation and in vitro evaluation of herb-drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy.
Patil PH; Birangal S; Shenoy GG; Rao M; Kadari S; Wankhede A; Rastogi H; Sharma T; Pinjari J; Puralae Channabasavaiah J
Phytother Res; 2022 Oct; 36(10):3988-4001. PubMed ID: 35778986
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Effects of
Seo HJ; Ji SB; Kim SE; Lee GM; Park SY; Wu Z; Jang DS; Liu KH
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802239
[No Abstract] [Full Text] [Related]
32. Methylophiopogonanone A is a naturally occurring broad-spectrum inhibitor against human UDP-glucuronosyltransferases: Inhibition behaviours and implication in herb-drug interactions.
Zhou QH; Zhu GH; Song YQ; Que YF; He QQ; Tu DZ; Zeng HR; Qin WW; Ai CZ; Ge GB
Basic Clin Pharmacol Toxicol; 2021 Dec; 129(6):437-449. PubMed ID: 34478607
[TBL] [Abstract][Full Text] [Related]
33. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects.
Li Y; Ning J; Wang Y; Wang C; Sun C; Huo X; Yu Z; Feng L; Zhang B; Tian X; Ma X
Toxicol Lett; 2018 Sep; 294():27-36. PubMed ID: 29753067
[TBL] [Abstract][Full Text] [Related]
34. Reversible and Irreversible Inhibition of Cytochrome P450 Enzymes by Methylophiopogonanone A.
Tu DZ; Mao X; Zhang F; He RJ; Wu JJ; Wu Y; Zhao XH; Zheng J; Ge GB
Drug Metab Dispos; 2020 Jun; 49(6):459-469. PubMed ID: 33811108
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
36. Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition.
Chen J; Liu J; Huang Y; Li R; Ma C; Zhang B; Wu F; Yu W; Zuo X; Liang Y; Wang Q
Drug Metab Rev; 2021 Nov; 53(4):491-507. PubMed ID: 33905669
[TBL] [Abstract][Full Text] [Related]
37. MDR- and CYP3A4-mediated drug-herbal interactions.
Pal D; Mitra AK
Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
[TBL] [Abstract][Full Text] [Related]
38. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
Chang Y; Fang WB; Lin SN; Moody DE
Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
[TBL] [Abstract][Full Text] [Related]
39. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.
Loretz C; Ho MD; Alam N; Mitchell W; Li AP
Drug Metab Dispos; 2020 Oct; 48(10):1084-1091. PubMed ID: 32719085
[TBL] [Abstract][Full Text] [Related]
40. Interactions between phytochemicals from traditional Chinese medicines and human cytochrome P450 enzymes.
Wu JJ; Ai CZ; Liu Y; Zhang YY; Jiang M; Fan XR; Lv AP; Yang L
Curr Drug Metab; 2012 Jun; 13(5):599-614. PubMed ID: 22475333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
